Insilico Medicine Partners with Takeda to Accelerate AI-Powered Drug Discovery
Under the agreement, Insilico will lead the AI-driven discovery process to identify molecules that meet predefined scientific and early development criteria, while Takeda will leverage its global development capabilities to advance selected candidates through clinical validation.

